The nation of Zimbabwe has turned down a substantial US health deal worth $367m (272 million pounds) spanning five years over the United States' request for confidential information.
This move came to light following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".
An official spokesman has since clarified that the United States was demanding access to health data for scientific study and commercial purposes while refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for continued negotiations to secure a agreement suitable to all parties so the nation's critical HIV programme can proceed.
Broader Context
This development follows a similar situation in Kenya, where a court halted a related health funding agreement after legal challenges were filed about the safety of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had managed assistance for the American government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and accountability.
Based on statements, 16 nations in Africa have so far signed similar agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data for a long time, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our citizens if a new pandemic arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures already established via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This framework is designed to guarantee that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
A leading public health body stated it acknowledged the government's concerns, but recommended that negotiations must proceed since much of the nation's Aids initiatives depended on international support.
"In cases where technical issues arise, including those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal highlights the continuing tensions between receiving much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.